Literature DB >> 766952

Second malignant neoplasms associated with immunosuppressive medications.

I Penn.   

Abstract

Previous studies have shown that immunosuppressive therapy permits the growth and spread of inadvertently transplanted malignant cells in man, and, in addition, is associated with a 5 to 6% incidence of de novo cancers in organ homograft recipients who were apparently free of cancer before and at the time of transplantation. In the present report two further groups of patients were studied. There was a 4% incidence of new tumors in 101 organ homograft recipient- who had had pre-existing cancers. The immunosuppressive effects of cancer chemotherapeutic agents may have been responsible for the development of 166 new malignancies in 160 patients who received treatment for 161 neoplasms. This does not contraindicate the use of chemotherapy in patients with advanced or widespread neoplasms, as the occasional development of new malignancies is far outweighed by the many months or years of control of the original tumors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 766952     DOI: 10.1002/1097-0142(197602)37:2+<1024::aid-cncr2820370806>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Remission of acute myelogenous leukemia complicating Waldenström macroglobulinemia.

Authors:  M K Effron; J Rosenbaum; P L Greenberg
Journal:  West J Med       Date:  1978-10

2.  Radiation-induced spinal cord glioma subsequent to treatment of Hodgkin's disease: case report and review.

Authors:  Laurent Riffaud; Marc Bernard; Thierry Lesimple; Xavier Morandi
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.

Authors:  Wen-Fang Cheng; Chien-Nan Lee; Yi-Ning Su; Ming-Cheng Chang; Wen-Chun Hsiao; Chi-An Chen; Chang-Yao Hsieh
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

4.  Sister chromatid exchange in lymphocytes from patients with acute lymphoblastic leukemia.

Authors:  M Otter; C G Palmer; R L Baehner
Journal:  Hum Genet       Date:  1979-11       Impact factor: 4.132

5.  Second malignant neoplasms in Hodgkin's disease.

Authors:  E P Getaz
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma.

Authors:  M Markman
Journal:  West J Med       Date:  1985-08

7.  Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease.

Authors:  R A Matthay; S K Zorn; M S Mitchell; R J Papac
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

Review 8.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

9.  Chondrosarcoma in children subsequent to other malignant tumours in different locations.

Authors:  D Vanel; C Coffre; L Zemoura; O Oberlin
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

10.  Giant cavernous hemangioma of the liver and multiple primary malignant tumors in a patient with suspected familial inhibition of natural killer cell activity--a case report.

Authors:  T Tomiyama; K Uchida; K Yoshida; T Muto; H Saito; K Nemoto; Z Inoue; T Morita; H Miyakoshi; K Tamura
Journal:  Jpn J Surg       Date:  1989-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.